# Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis

> **NCT03048383** · PHASE4 · COMPLETED · sponsor: **University of Utah** · enrollment: 71 (actual)

## Conditions studied

- Facial Nerve Injuries
- Facial Paresis Associated With Facial Nerve Dysfunction
- Facial Asymmetry
- Synkinesis

## Interventions

- **DRUG:** OnabotulinumtoxinA Injectable Product
- **DRUG:** AbobotulinumtoxinA Injectable Product
- **DRUG:** Incobotulinumtoxin A Injectable Product

## Key facts

- **NCT ID:** NCT03048383
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2017-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03048383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03048383, "Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03048383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*